Mount Sinai Logo

Elizabeth A. Raetz

  • ADJUNCT ASSOCIATE PROFESSOR Pediatrics
Print ProfilePrint Profile

Biography

    Dr. Raetz is board certified in Pediatric Hematology/Oncology by the American Board of Pediatrics.

    Dr. Raetz's areas of expertise include: Childhood leukemia and Non-Hodgkin lymphoma.

Awards

  • 1992 -
    Harry Waisman Award
    University of Wisconsin Medical School

  • 1991 -
    Alpha Omega Alpha
    University of Wisconsin Medical School

Research

Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma

Publications

Raetz E, Perkins SL, Carlson MA, Schooler KP, Carroll WL, Virshup DM. The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am J Pathol 2002 Sep; 161(2): 875-83.

Moos PJ, Raetz EA, Carlson MA, Szabo A , Smith FE, Willman C , Wei Q , Hunger SP, Carroll WL. Identification of gene expression profiles that segregate patients with childhood leukemia. lin Cancer Res 2002 Oct; 8(10): 3118-30.

Raetz E, Perkins S , Davenport V , Cairo MS. B large-cell lymphoma in children and adolescents [review]. Cancer Treat Rev 2003 Apr; 29: 91-8.

Raetz E, Kim MK, Moos P, Carlson M , Bruggers C , Hooper DK, Foot L , Liu T , Seeger R , Carroll WL. Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer 2003 Aug; 15: 841-53.

Raetz EA, Moos PJ. Impact of Microarray Technology in Clinical Oncology [review]. Cancer Investigation 2004; 22(2): 312-20.

Carroll WL, Raetz EA. Building better therapy for children with acute lymphoblastic leukemia. Cancer Cell 2005 Apr; 7(4): 289-91.

Cairo MS, Raetz E, Lim MS, Davenport V, Perkins SL. Childhood and adolescent non-Hodgkin lymphoma: New insights in biology and critical challenges for the future. Pediatr Blood Cancer 2005 Nov; 45(6): 753-69.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Raetz is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central